NFKBIE and B-cell chronic lymphocytic leukemia: Compared to NFKBIE-wild-type (WT) patients, NFKBIE-mutated CLL cells showed reduced IκBε protein levels and decreased p65 inhibition, along with increased phosphorylation and nuclear translocation of p65 (ref. 2).